ArticleFrontiers in endocrinology2017

Receptor-Mediated Melanoma Targeting with Radiolabeled α-Melanocyte-Stimulating Hormone: Relevance of the Net Charge of the Ligand.

Jean-Philippe Bapst et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.